Source: Arcadia Biosciences

Arcadia Biosciences Inc., an agricultural biotechnology company focused on developing technologies and products that benefit the environment and human health, has raised $15 million in financing from its current investors. The transaction was led by Exeter Life Sciences, with full participation of other key shareholders including CMEA Ventures, BASF Venture Capital America Inc., and Saints Capital.

The company will use proceeds from the financing to fund and complete the launch of Arcadia's GLA Safflower Oil